Variceal bleeding in patients with cirrhosis: What are the unanswered questions?;Rupture de varices œsophagiennes chez les malades atteints de cirrhose : quelles sont les questions encore sans réponse ?

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 6-7, 2008, Pages 614-619

  Thabut, D ^a   Rudler, M ^a   Massard, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; ERYTHROMYCIN; NORFLOXACIN; OCTREOTIDE; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN;

ARTICLE; BLEEDING; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIVER CIRRHOSIS; RECOMMENDED DRUG DOSE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICOSIS; VARIX BLEEDING; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE;

ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS;

EID: 50649110951     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.03.019     Document Type: Article

References (46)

1. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Levy V.G., and Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
2. Cardenas A., Gines P., Uriz J., Bessa X., Salmeron J.M., Mas A., et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34 (2001) 671-676
3. D'Amico G., and De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
4. McCormick P.A., and O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 49 (2001) 682-685
5. Bosch J., Abraldes J.G., and Groszmann R. Current management of portal hypertension. J Hepatol 38 Suppl. 1 (2003) S54-68
6. o 2):324-34.
7. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
8. Garcia-Tsao G., Sanyal A.J., Grace N.D., and Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007) 922-938
9. Levacher S., Letoumelin P., Pateron D., Blaise M., Lapandry C., and Pourriat J.L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346 (1995) 865-868
10. o 2 (2004) B194-202
11. Cirera I., Feu F., Luca A., Garcia-Pagan J.C., Fernandez M., Escorsell A., et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 22 (1995) 106-111
12. Escorsell A., Bandi J.C., Andreu V., Moitinho E., Garcia-Pagan J.C., Bosch J., et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120 (2001) 161-169
13. Villanueva C., Ortiz J., Minana J., Soriano G., Sabat M., Boadas J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
14. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
15. Bosch J., Kravetz D., and Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 80 (1981) 518-525
16. Moitinho E., Planas R., Banares R., Albillos A., Ruiz-del-Arbol L., Galvez C., et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol 35 (2001) 712-718
17. Blaise M., Pateron D., Trinchet J.C., Levacher S., Beaugrand M., and Pourriat J.L. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 20 (1994) 34-38
18. Bernard B., Cadranel J.F., Valla D., Escolano S., Jarlier V., and Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108 (1995) 1828-1834
19. Goulis J., Armonis A., Patch D., Sabin C., Greenslade L., and Burroughs A.K. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27 (1998) 1207-1212
20. Bernard B., Grange J.D., Khac E.N., Amiot X., Opolon P., and Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
21. Hou M.C., Lin H.C., Liu T.T., Kuo B.I., Lee F.Y., Chang F.Y., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39 (2004) 746-753
22. Rimola A., Garcia-Tsao G., Navasa M., Piddock L.J., Planas R., Bernard B., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32 (2000) 142-153
23. Fernandez J., Ruiz del Arbol L., Gomez C., Durandez R., Serradilla R., Guarner C., et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131 (2006) 1049-1056
24. Lau J.Y., Sung J.J., Lee K.K., Yung M.Y., Wong S.K., Wu J.C., et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343 (2000) 310-316
25. Avgerinos A., Nevens F., Raptis S., and Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 350 (1997) 1495-1499
26. Cales P., Masliah C., Bernard B., Garnier P.P., Silvain C., Szostak-Talbodec N., et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 344 (2001) 23-28
27. Lachérade J., Pasquereau V., Vitte R., De Jongue B., Fangio P., Eugène C., et al. Hémorragies digestives hautes admises en réanimation pendant les horaires de garde : fibroscopie œsogastroduodénale réalisée en urgence ou différée : impact d'un algorithme décisionnel (résumé). Gastroenterol Clin Biol 29 Hors-Série 1 (2005) A1
28. Carbonell N., Pauwels A., Serfaty L., Boelle P.Y., Becquemont L., and Poupon R. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 101 (2006) 1211-1215
29. Coffin B., Pocard M., Panis Y., Riche F., Laine M.J., Bitoun A., et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 56 (2002) 174-179
30. Frossard J.L., Spahr L., Queneau P.E., Giostra E., Burckhardt B., Ory G., et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology 123 (2002) 17-23
31. Azoulay D., Castaing D., Majno P., Saliba F., Ichai P., Smail A., et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35 (2001) 590-597
32. Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?. J Hepatol 35 (2001) 658-660
33. Burroughs A.K., and Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 19 (1999) 457-473
34. Monescillo A., Martinez-Lagares F., Ruiz-del-Arbol L., Sierra A., Guevara C., Jimenez E., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40 (2004) 793-801
35. Bureau C., Garcia-Pagan J.C., Otal P., Pomier-Layrargues G., Chabbert V., Cortez C., et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126 (2004) 469-475
36. Thabut D., Imbert-Bismut F., Cazals-Hatem D., Messous D., Muntenau M., Valla D.C., et al. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 26 (2007) 359-368
37. Vizzutti F., Arena U., Romanelli R.G., Rega L., Foschi M., Colagrande S., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45 (2007) 1290-1297
38. Carrion J.A., Navasa M., Bosch J., Bruguera M., Gilabert R., and Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 12 (2006) 1791-1798
39. Abraldes J.G., Villanueva C., Banares R., Aracil C., Catalina M.V., Garci A.P.J.C., et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 48 (2008) 229-236
40. Reverter J.C. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost 4 (2006) 717-720
41. Ben-Ari Z., Cardin F., McCormick A.P., Wannamethee G., and Burroughs A.K. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 31 (1999) 443-450
42. Bosch J., Thabut D., Bendtsen F., D'Amico G., Albillos A., Gonzalez Abraldes J., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
43. Bosch J., Thabut D., Albillos A., Carbonell N., Spicak J., Massarrd J., et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomised, controlled trial. Hepatology 47 5 (2008) 1604-1614
44. Romero-Castro R., Jimenez-Saenz M., Pellicer-Bautista F., Gomez-Parra M., Arguelles Arias F., Guerrero-Aznar M.D., et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2 (2004) 78-84
45. Bellot P, García-Pagán JC, Bosch J. Primary prophylaxis of esophageal variceal bleeding in cirrhosis. Gastroenterol Clin Biol, 2008 in press
46. Abou-Alfa G.K., Schwartz L., Ricci S., Amadori D., Santoro A., Figer A., et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24 (2006) 4293-4300